版本:
中国

BRIEF-Nabriva Therapeutics to present data at ASM microbe supporting ongoing phase 3 clinical development program for lefamulin

June 2 Nabriva Therapeutics Ag

* Nabriva Therapeutics to present data at ASM microbe supporting ongoing phase 3 clinical development program for lefamulin Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐